#depression-treatment

#depression-treatment

The FDA approved Spravato, a nasal spray for treatment-resistant depression, offering quicker symptom relief than traditional oral antidepressants.

The FDA has approved Spravato as a standalone treatment for depression, marking a significant shift in its usage guidelines.

Psilocybin in clinical trials for mental health relief, impacting brain's sense of self and potentially interrupting negative thought loops.

Psilocybin and its effects on brain connectivity offer potential mental health benefits, particularly in treating depression and enhancing psychotherapy outcomes.

SAD is a serious depression caused by reduced sunlight in winter, while winter blues are milder and linked to lifestyle changes.

Researchers are investigating the therapeutic potential of 5-MeO-DMT from the Sonoran Desert toad for mental health disorders.

Brexanolone, mimicking allopregnanolone, was approved as the first PPD treatment in 2019, marking a significant advancement in depression therapy.

Psilocybin shows potential in treating depression with noted improvements in social functioning and life meaning, comparable to traditional antidepressants.

Psilocybin in magic mushrooms has a long-lasting effect on the brain, influencing space, time perception, self, and aiding in depression treatment.

Matthew Perry's death was ruled accidental, linked to ketamine and other factors.

An arrest related to the drug source has been made as part of the investigation.

Ketamine tablet could revolutionize depression treatment, offering a more convenient alternative to intravenous administration with reduced side effects.

The pandemic-era change by the DEA significantly altered access to prescription medications, including ketamine, raising questions about its use in depression treatment.